Pascale Witz - Net Worth and Insider Trading
Pascale Witz Net Worth
The estimated net worth of Pascale Witz is at least $306,897 dollars as of 2024-09-20. Pascale Witz is the Director of Revvity Inc and owns about 2,446 shares of Revvity Inc (RVTY) stock worth over $300,613. Pascale Witz is also the Director of Regulus Therapeutics Inc and owns about 3,785 shares of Regulus Therapeutics Inc (RGLS) stock worth over $6,283. Details can be seen in Pascale Witz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pascale Witz has not made any transactions after 2019-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pascale Witz
Pascale Witz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pascale Witz owns 4 companies in total, including Horizon Therapeutics PLC (HZNP) , Regulus Therapeutics Inc (RGLS) , and Revvity Inc (RVTY) among others .
Click here to see the complete history of Pascale Witz’s form 4 insider trades.
Insider Ownership Summary of Pascale Witz
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HZNP | Horizon Therapeutics PLC | 2017-08-02 | director |
RGLS | Regulus Therapeutics Inc | 2019-05-07 | director |
RVTY | Revvity Inc | 2019-11-21 | director |
2019-01-22 | director |
Pascale Witz Latest Holdings Summary
Pascale Witz currently owns a total of 2 stocks. Among these stocks, Pascale Witz owns 2,446 shares of Revvity Inc (RVTY) as of November 21, 2019, with a value of $300,613 and a weighting of 97.95%. Pascale Witz also owns 3,785 shares of Regulus Therapeutics Inc (RGLS) as of May 7, 2019, with a value of $6,283 and a weighting of 2.05%.
Latest Holdings of Pascale Witz
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RVTY | Revvity Inc | 2019-11-21 | 2,446 | 122.90 | 300,613 |
RGLS | Regulus Therapeutics Inc | 2019-05-07 | 3,785 | 1.66 | 6,283 |
Holding Weightings of Pascale Witz
Pascale Witz Form 4 Trading Tracker
According to the SEC Form 4 filings, Pascale Witz has made a total of 1 transactions in Revvity Inc (RVTY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Revvity Inc is the sale of 1,043 shares on November 21, 2019, which brought Pascale Witz around $94,569.
According to the SEC Form 4 filings, Pascale Witz has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 2,963 shares on May 7, 2019, which cost Pascale Witz around $32,000.
Insider Trading History of Pascale Witz
- 1
Pascale Witz Trading Performance
GuruFocus tracks the stock performance after each of Pascale Witz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pascale Witz is -49.23%. GuruFocus also compares Pascale Witz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pascale Witz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pascale Witz's insider trading performs compared to the benchmark.
Performance of Pascale Witz
Pascale Witz Ownership Network
Pascale Witz Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Pascale Witz is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Pascale Witz Mailing Address
Above is the net worth, insider trading, and ownership report for Pascale Witz. You might contact Pascale Witz via mailing address: C/o Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego Ca 92121.